Phoenix Biotech Acquisition a Aktie
WKN DE: A3DE3Y / ISIN: US71902K1051
17.06.2025 14:33:40
|
CERo Therapeutics Gets Orphan Drug Status For CER-1236 In Acute Myeloid Leukemia
(RTTNews) - CERo Therapeutics Holdings, Inc., (CERO) Tuesday said that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for the company's lead drug candidate CER-1236, for the treatment of acute myeloid leukemia (AML).
A Phase 1 study of CER-1236 in AML is underway.
The ODD designation provides benefits including financial incentives, regulatory assistance, and potential market exclusivity.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Phoenix Biotech Acquisition Corp Registered Shs -A-mehr Nachrichten
Keine Nachrichten verfügbar. |